- Investor Relations
- Events & Presentations
- Stock Information
- Investor Resources
- Events & Presentations
- Stock Information
- Investor Resources
Board of Directors
|Peter R. Huntsman|
Chairman of the Board, President and Chief Executive Officer
Peter R. Huntsman is Chairman of the Board of our company since January 2018. Mr. Huntsman has served as a director of our company and affiliated companies since 1994. Mr. Huntsman is also our President and Chief Executive Officer. Prior to his appointment in July 2000 as Chief Executive Officer, Mr. Huntsman had served as President and Chief Operating Officer since 1994. In 1987, after working for Olympus Oil since 1983, Mr. Huntsman joined Huntsman Polypropylene Corporation as Vice President before serving as Senior Vice President and General Manager. Mr. Huntsman has also served as Senior Vice President of Huntsman Chemical Corporation and as a Senior Vice President of Huntsman Packaging Corporation, a former subsidiary of our company. Additionally, Mr. Huntsman is Chairman of the Board of Directors of Venator Materials, a publicly traded subsidiary of Huntsman.
|Nolan D. Archibald|
Vice Chairman of the Board, Chairman of the Nominating and Corporate Governance Committee and Lead Independent Director
Mr. Archibald has served as one of our directors since March 2005. He is currently our Vice Chairman and Lead Independent Director. Mr. Archibald is also Chairman of the Nominating and Corporate Governance Committee and a member of our Compensation Committee. Mr. Archibald served as Executive Chairman of Stanley Black & Decker, Inc., a consumer and commercial products company, since March 2010 to March 2013. He served as President and Chief Executive Officer of The Black & Decker Corporation from 1986 until 2010, as well as Chairman of the Board of The Black & Decker Corporation from 1987 until 2010. In addition, Mr. Archibald serves as a director of Lockheed Martin Corporation and Brunswick Corporation.
|M. Anthony Burns|
Chairman of the Audit Committee and Director
Mr. Burns has served as one of our directors since March 2010. He is Chairman of the Audit Committee and a member of the Governance Committee. Mr. Burns currently serves as Chairman Emeritus of Ryder System, Inc., a provider of transportation and logistics services, a position that he has held since 2002. Mr. Burns served in several positions at Ryder until his retirement in 2002, including Chairman of the Board from 1985 to 2002, Chief Executive Officer from 1983 to 2000 and President from 1979 to 1999. Prior to joining Ryder, Mr. Burns served in management of Mobil Oil Corporation. He is a Life Trustee of the University of Miami in Florida and is active in cultural and civic organizations in Florida.
|Wayne A. Reaud|
Chairman of the Litigation Committee and Director
Mr. Reaud has served as one of our directors since March 2005. Mr. Reaud currently serves as Chairman of our Litigation Committee, which was formed in November 2008, and he serves as a member of our Compensation Committee. Mr. Reaud is a trial lawyer and the founder of the law firm of Reaud, Morgan & Quinn. For over 30 years, he has represented clients in significant cases involving personal injury, product and premises liability, toxic torts and business litigation. Mr. Reaud has handled first impression mass tort litigation involving asbestos premises liability claims, including the largest asbestos product liability class action lawsuit in the history of Texas courts. He also represented the State of Texas in its landmark litigation against the tobacco industry. Mr. Reaud currently serves as Chairman of the Board of the Beaumont Foundation of America and is a Director of the Reaud Charitable Foundation. He is a Life Fellow of the Texas Bar Foundation and a Fellow of the International Society of Barristers, a member of the Philosophical Society and a member of the State Bar of Texas Grievance Committee. Mr. Reaud was chosen as the Most Distinguished Alumni of Texas Tech University Law School in 1998 and also chosen as the Most Distinguished Alumni of Lamar University in 2006. Mr. Reaud was awarded the Honorary Order of the Coif by the University of Texas in 2011. He is listed in Best Lawyers in America.
|Alvin V. Shoemaker|
Chairman of the Compensation Committee and Director
Mr. Shoemaker has served as one of our directors since March 2005. He is Chairman of the Compensation Committee and a member of our Audit Committee. Mr. Shoemaker has been a private investor since his retirement as Chairman of the Board of First Boston Corporation and First Boston, Inc. in 1989, a position he assumed in 1983. Mr. Shoemaker also serves as a director of Wynn Resorts Limited.
|Dr. Mary C. Beckerle|
Dr. Beckerle has served as one of our directors since May 2011. She is a member of our Audit Committee and our Governance Committee. Dr. Beckerle is an internationally recognized scientist who has served on numerous national scientific boards and committees, including the Advisory Committee to the Director of the U.S. National Institutes of Health. She currently serves on the Board of Directors of the American Association for Cancer Research. She is also a member of cancer policy and advisory boards at Harvard University, Georgetown University, the University of Pennsylvania, the National Center for Biological Sciences in Bangalore (India), and the Mechanobiology Institute of the National University of Singapore. She also serves as a director of Johnson & Johnson. Dr. Beckerle is a Distinguished Professor of Biology in the College of Science at the University of Utah, which she joined in 1986. Since 2006, Dr. Beckerle has served as Chief Executive Officer and Director of Huntsman Cancer Institute at the University of Utah. Dr. Beckerle served as President of the American Society for Cell Biology in 2006, held a Guggenheim Fellowship at the Curie Institute in Paris, and is an elected Fellow of the American Academy of Arts and Sciences.
|Sir Robert J. Margetts|
Sir Robert has served as one of our directors since August 2010. He is a member of our Audit Committee and our Governance Committee. He currently serves as Deputy Chairman of OJSC Uralkali, a publicly traded potash fertilizer producer, and on the boards of a number of privately held companies. Sir Robert previously served as a director of Anglo American PLC from 1998 to 2010, Chairman of Legal & General Group PLC from 2000 until 2010 and Chairman of BOC Group PLC from 2002 to 2006. Sir Robert served as Chairman – Europe of Huntsman Corporation from 2000 to August 2010. He worked for Imperial Chemical Industries (ICI) in various levels of increasing responsibility from 1969 to 2000, where he ultimately served as the Vice Chairman of its Main Board.
|Jon M. Huntsman (1937-2018)|
Jon M. Huntsman was our founder and Chairman Emeritus of our company until his passing on February 2, 2018. Widely regarded as one of his generation’s great industrialists, Mr. Huntsman leaves behind an extraordinary legacy. He was a pioneer in the chemical industry, having founded the Huntsman Container Company in 1970, which revolutionized packaging and plastics, and was the initial predecessor to what is today known as Huntsman Corporation. In 1974, Mr. Huntsman created the "clamshell" container for fast-food sandwiches and went on to invent as many as 30 other popular products, including the first plastic plates and bowls.
In 1982, Mr. Huntsman formed Huntsman Chemical Corporation in Salt Lake City. While serving as its Chairman and CEO, he led the Company through constant, rapid growth with myriad impeccably timed and well-integrated acquisitions. Today Huntsman Corporation and Venator Corporation (a public subsidiary of Huntsman Corporation) together represent an $11 billion global manufacturer and marketer of chemicals. In December 2017, the Board of Directors of Huntsman Corporation named Mr. Huntsman Director and Chairman Emeritus, and elected his son, Peter R. Huntsman, Chairman, President and CEO.
In his heart, Mr. Huntsman was first a philanthropist, and his life’s ambition much greater than business. His mission was to find a cure for cancer and alleviate its ravaging effects on mankind. In 1995, he contributed $100 million to establish the Huntsman Cancer Institute, a pioneer in genetic research and treatment and today one of the world’s most renowned cancer institutes and hospitals, located in Salt Lake City.